Market Pulse LIVECAST Terminal Politics Macro Calendar/FX

More

Schedule Disclosure Wire Crypto Search

Market Pulse LIVECAST

Menu

Home Market Pulse LIVECAST Terminal Politics Macro Calendar/FX Schedule Disclosure Wire Crypto Search

Live News EQUITY L impact Jun 29, 2026, 08:30 AM UTC

UK Mortgage Approvals

UK Mortgage Approvals

SQUAWKNEWS

UK Mortgage Approvals

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Verizon expects record loss of about $700M to $800M in Q2. $VZ Verizon expects record loss of about $700M to $800M in Q2. $VZ L impact | EQUITY | Jun 29, 2026, 10:29 AM UTC HC Wainwright & Co. Reiterates Buy on Monopar Therapeutics, Maintains $105 Price Target HC Wainwright maintains Buy rating on Monopar Therapeutics. M impact | EQUITY | Jun 29, 2026, 10:26 AM UTC Needham Maintains Buy on Revolution Medicines, Raises Price Target to $235 Needham raises price target on Revolution Medicines to $235 M impact | EQUITY | Jun 29, 2026, 10:24 AM UTC Comcast To Suspend Share Buyback Program Comcast To Suspend Share Buyback Program M impact | EQUITY | Jun 29, 2026, 10:24 AM UTC MSFT Is Down 23% In 2026: Why This Strategist Says Investors Are 'Significantly Overselling' The Stock Futurum Equities strategist Shay Boloor is buying Microsoft stock, arguing investors are overselling the company due to short-term fears. M impact | EQUITY | Jun 29, 2026, 10:20 AM UTC HC Wainwright & Co. Upgrades Prime Medicine to Buy, Announces $8 Price Target HC Wainwright & Co. analyst Arthur He upgrades Prime Medicine (NASDAQ: PRME ) from Neutral to Buy and announces $8 price target. M impact | EQUITY | Jun 29, 2026, 10:13 AM UTC